RARA CRAFT DATABASE for FDA Medical Devices
510(k)K241944

FDA DEVICE FACTS

AGILON® XO Shoulder Replacement System

Implantcast GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 10, 2025PRODUCT CODEKWT

Indications for use

The AGILON® XO Shoulder Replacement System is indicated for use for total or hemi shoulder replacement in cases of: * Non- inflammatory degenerative joint disease including osteoarthritis and avascular necrosis, * Post-traumatic osteoarthritis, ¢ Fractures, * Rheumatoid arthritis. The main indications for the implantation of an AGILON® hemi shoulder prosthesis are: * Multi-fragmental comminuted fractures of the humeral head, ¢ 3- and 4-Fragment-fractures of the proximal humerus, * Head-splitting fractures, * Dislocated head-splitting fractures, * Humeral head depression with more than 40% of joint surface depressed, * Interlocking chronic dislocation with deep HILL-SACHS lesion, ¢ Fracture instability following internal fixation attempt in 3-fragment and 4-fragment fractures (secondary dislocation, material loosening), ¢ Posttraumatic humeral head necrosis, * Omarthrosis. AGILON® CTA heads are destined for treatment of stable types of rotator cuff tear arthropathy. In order to achieve satisfactory results with the CTA heads the fornix humeri and the subscapularis tendon must be intact. A CTA cap is intended for the use as a hemi-arthroplasty, to treat a patient after an inverse shoulder has failed. It is not combined with a glenoid implant. It can be used in primary and revision cases. The main indications for the implantation of an AGILON® inverse (reverse) shoulder prosthesis are: * Rotator cuff tear arthropathy, * Chronic trauma shoulder, * Decentering of the humeral head after implantation of a humeral head prosthesis. Please note, that the patient’s joint must be anatomically and structurally suited to receive the selected implant(s), and a functional deltoid muscle is necessary. In case of revision surgery the available bone stock has to be evaluated to allow for implantation of well-fixed stems. Conversion of the system can be performed in revision cases as follows: * From Hemi Shoulder Arthroplasty to Anatomic Total Shoulder Arthroplasty * From Hemi Shoulder Arthroplasty to Hemi CTA Shoulder Arthroplasty * From Hemi Shoulder Arthroplasty to Inverse (Reverse) Total Shoulder Arthroplasty * From Inverse (Reverse) Total Shoulder Arthroplasty to Hemi Shoulder Arthroplasty as salvage procedure * From Inverse (Reverse) Total Shoulder Arthroplasty to Hemi CTA Shoulder Arthroplasty as salvage procedure * From Anatomic Total Shoulder Arthroplasty to Inverse (Reverse) Total Shoulder Arthroplasty * From Anatomic Total Shoulder Arthroplasty to Hemi CTA Shoulder Arthroplasty The device is intended for adults. The AGILON® XO Shoulder Replacement System Titanium alloy stems are intended for cementless fixation. The PE-glenoids of the AGILON® XO Shoulder Replacement System are intended for cemented fixation. The glenoid cementless is intended for cementless use with the addition of screws for fixation.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026